Csilla Kiss

Title: **Innovator Csilla Kiss: Pioneering High-Purity Pharmaceutical Processes**

Introduction

Csilla Kiss, an accomplished inventor located in Budapest, Hungary, has made significant contributions to the field of pharmaceuticals. With a passion for innovation, she holds a patent that showcases her expertise in developing high-purity chemical processes essential for pharmaceutical applications.

Latest Patents

Kiss's notable patent is titled "Process for the preparation of high-purity 1-(3-chlorophenyl)-4-methyl-7,8-dimethoxy-5 H-2,3-benzodiazepine". This invention describes a unique methodology for synthesizing the compound in high purity, which is crucial for ensuring the effectiveness and safety of pharmaceutical products. The intricate process involves the reaction of 1 mole of 2-acetonyl-3'-chloro-4,5-dimethoxybenzophenone with 3-7 moles of hydrazine hydrate under controlled conditions, ensuring the absence of air oxygen to enhance the quality of the final product. The purification involves recrystallization from an appropriate aliphatic alcohol, allowing for the achievement of high purity standards.

Career Highlights

As a member of Egis Gyogyszergyar Rt., Csilla Kiss has established herself as a key contributor to pharmaceutical innovation. Her research and development work in high-purity compound preparation emphasizes her commitment to advancing pharmaceutical technologies and enhancing drug formulation methodologies.

Collaborations

Throughout her career, Kiss has collaborated with talented professionals such as Gyorgy Somogyi and Peter Botka. Their combined expertise and collaborative efforts have contributed to the successful development of high-quality pharmaceutical processes, allowing for advancements in drug manufacturing.

Conclusion

Csilla Kiss's innovations in the preparation of high-purity pharmaceutical compounds have positioned her as a noteworthy inventor in the field. Her dedication to research and collaboration not only enhances the capabilities of her company, Egis Gyogyszergyar Rt., but also contributes to the broader pharmaceutical landscape, paving the way for future advancements in drug safety and efficacy.